The impact of early target attainment of vancomycin in critically ill patients with confirmed Gram-positive infection: A retrospective cohort study

par Khalid Al Sulaiman, Abdulrahman Alshaya, Ohoud Aljuhani, Amjad Alsaeed, Nadiyah Alshehri, Ramesh Vishwakarma, Hamdan Alzahrani, Sara Althewaibi, Nawaf Alghamdi, Khalid Alhelal, Aisha Alharbi, Shmeylan Al Harbi
Publié 2021

Author Correction: Ascorbic acid as an adjunctive therapy in critically ill patients with COVID-19: a propensity score matched study

par Khalid Al Sulaiman, Ohoud Aljuhani, Khalid Bin Saleh, Hisham A. Badreldin, Abdullah Al Harthi, Mohammed Alenazi, Aisha Alharbi, Rahmah Algarni, Shmeylan Al Harbi, Abdullah M. Alhammad, Ramesh Vishwakarma, Sarah Aldekhyl
Publié 2021

Ascorbic acid as an adjunctive therapy in critically ill patients with COVID-19: a propensity score matched study

par Khalid Al Sulaiman, Ohoud Aljuhani, Khalid Bin Saleh, Hisham A. Badreldin, Abdullah Al Harthi, Mohammed Alenazi, Aisha Alharbi, Rahmah Algarni, Shmeylan Al Harbi, Abdullah M. Alhammad, Ramesh Vishwakarma, Sarah Aldekhyl
Publié 2021

Association between tocilizumab and emerging multidrug-resistant organisms in critically ill patients with COVID-19: A multicenter, retrospective cohort study

par Ohoud Aljuhani, Khalid Al Sulaiman, Adel Alshabasy, Khalid Eljaaly, Abdulrahman I. Al Shaya, Haytham Noureldeen, Mohammed Aboudeif, Bodoor Al Dosari, Amina Alkhalaf, Ghazwa B. Korayem, Muneera M. Aleissa, Hisham A. Badreldin, Shmeylan Al Harbi, Abdullah Alhammad, Ramesh Vishwakarma
Publié 2021

Appropriateness of Using Vitamin K for the Correction of INR Elevation Secondary to Hepatic Disease in Critically ill Patients: An Observational Study

par Khalid Al Sulaiman, Mashael Al Mutairi, Omar Al Harbi, Alanoud Al Duraihim, Sara Aldosary, Haifa Al Khalil, Abdulrahman Al Shaya, Shmeylan Al Harbi, Nouf Alotaibi, Kholoud Al Aamer, Ramesh Vishwakarma, Mohammed Al Asiri, Ohoud Aljuhani, Abdulmalik Al Katheri, Abdulkareem M. Al Bekairy
Publié 2021